Author
Listed:
- Dounia Ben Amar
(University of Lyon, University Claude Bernard Lyon 1, MeLiS, CNRS UMR5284, INSERM U1314, NeuroMyoGene Institute)
- Karine Thoinet
(University of Lyon, University Claude Bernard Lyon 1, MeLiS, CNRS UMR5284, INSERM U1314, NeuroMyoGene Institute)
- Benjamin Villalard
(University of Lyon, University Claude Bernard Lyon 1, MeLiS, CNRS UMR5284, INSERM U1314, NeuroMyoGene Institute)
- Olivier Imbaud
(University of Lyon, University Claude Bernard Lyon 1, MeLiS, CNRS UMR5284, INSERM U1314, NeuroMyoGene Institute)
- Clélia Costechareyre
(Oncofactory SAS, 8 avenue Rockefeller)
- Loraine Jarrosson
(Oncofactory SAS, 8 avenue Rockefeller)
- Florie Reynaud
(University of Lyon, University Claude Bernard Lyon 1, MeLiS, CNRS UMR5284, INSERM U1314, NeuroMyoGene Institute)
- Julia Novion Ducassou
(University Grenoble Alpes, INSERM, CEA)
- Yohann Couté
(University Grenoble Alpes, INSERM, CEA)
- Jean-François Brunet
(Inserm, CNRS, École normale supérieure, PSL Research University)
- Valérie Combaret
(Laboratory of Translational Research, Léon Bérard Centre)
- Nadège Corradini
(Centre Léon Berard and Institut d’Hématologie et d’Oncologie Pédiatrique)
- Céline Delloye-Bourgeois
(University of Lyon, University Claude Bernard Lyon 1, MeLiS, CNRS UMR5284, INSERM U1314, NeuroMyoGene Institute)
- Valérie Castellani
(University of Lyon, University Claude Bernard Lyon 1, MeLiS, CNRS UMR5284, INSERM U1314, NeuroMyoGene Institute)
Abstract
Embryonic malignant transformation is concomitant to organogenesis, often affecting multipotent and migratory progenitors. While lineage relationships between malignant cells and their physiological counterparts are extensively investigated, the contribution of exogenous embryonic signals is not fully known. Neuroblastoma (NB) is a childhood malignancy of the peripheral nervous system arising from the embryonic trunk neural crest (NC) and characterized by heterogeneous and interconvertible tumor cell identities. Here, using experimental models mimicking the embryonic context coupled to proteomic and transcriptomic analyses, we show that signals released by embryonic sympathetic ganglia, including Olfactomedin-1, induce NB cells to shift from a noradrenergic to mesenchymal identity, and to activate a gene program promoting NB metastatic onset and dissemination. From this gene program, we extract a core signature specifically shared by metastatic cancers with NC origin. This reveals non-cell autonomous embryonic contributions regulating the plasticity of NB identities and setting pro-dissemination gene programs common to NC-derived cancers.
Suggested Citation
Dounia Ben Amar & Karine Thoinet & Benjamin Villalard & Olivier Imbaud & Clélia Costechareyre & Loraine Jarrosson & Florie Reynaud & Julia Novion Ducassou & Yohann Couté & Jean-François Brunet & Valér, 2022.
"Environmental cues from neural crest derivatives act as metastatic triggers in an embryonic neuroblastoma model,"
Nature Communications, Nature, vol. 13(1), pages 1-18, December.
Handle:
RePEc:nat:natcom:v:13:y:2022:i:1:d:10.1038_s41467-022-30237-3
DOI: 10.1038/s41467-022-30237-3
Download full text from publisher
Citations
Citations are extracted by the
CitEc Project, subscribe to its
RSS feed for this item.
Cited by:
- Cécile Thirant & Agathe Peltier & Simon Durand & Amira Kramdi & Caroline Louis-Brennetot & Cécile Pierre-Eugène & Margot Gautier & Ana Costa & Amandine Grelier & Sakina Zaïdi & Nadège Gruel & Irène Ji, 2023.
"Reversible transitions between noradrenergic and mesenchymal tumor identities define cell plasticity in neuroblastoma,"
Nature Communications, Nature, vol. 14(1), pages 1-18, December.
- Benjamin Villalard & Arjan Boltjes & Florie Reynaud & Olivier Imbaud & Karine Thoinet & Ilse Timmerman & Séverine Croze & Emy Theoulle & Gianluigi Atzeni & Joël Lachuer & Jan J. Molenaar & Godelieve A, 2024.
"Neuroblastoma plasticity during metastatic progression stems from the dynamics of an early sympathetic transcriptomic trajectory,"
Nature Communications, Nature, vol. 15(1), pages 1-19, December.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:13:y:2022:i:1:d:10.1038_s41467-022-30237-3. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.